Wei‐Ting Hwang

26.9k citations
272 papers · 21.2k · 16 hit papers · h-index 67

Impact in

  • Oncology top 0.1%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
  • Virology top 1%
    • HIV Research and Treatment

Papers in

    • CAR-T cell therapy research 33
    • Cancer Immunotherapy and Biomarkers 13
    • Breast Cancer Treatment Studies 26

Wei‐Ting Hwang

263 papers receiving 20.5k citations

Wei‐Ting Hwang's Hit Papers

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies 2025 · 53 citations
530+5+10Years since publication4008001.2k

Peers

Wei‐Ting Hwang
Comparison fields: 5 of 169
  • Oncology 7.9k
  • Virology 650
  • Cancer Research 1.5k
  • Genetics 845
  • Research and Theory 327
Replace ALFRED W. RADEMAKER with:
ALFRED W. RADEMAKER United States
Charles M. Balch United States
Thomas Matthew Habermann United States
Elizabeth S. Garrett-Mayer United States
Urania G. Dafni Greece
Sohee Park South Korea
Raul Correa Ribeiro United States
Robert N. Anderson United States
Thomas J. Smith United States
Jimmie C. Holland United States
Wei‐Ting Hwang relative to ALFRED W. RADEMAKER United States ALFRED W. RADEMAKER's profile →
Citations per field
00.5×5×10×15.6×
ALFRED W. RADEMAKER · 1×
Citations per year

Countries citing papers authored by Wei‐Ting Hwang

Since Specialization
Citations

This map shows the geographic impact of Wei‐Ting Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Hwang more than expected).

Fields of papers citing papers by Wei‐Ting Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ting Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Hwang. The network helps show where Wei‐Ting Hwang may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei‐Ting Hwang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei‐Ting Hwang Line = papers co-authored together Wei‐Ting Hwang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
Hit paper breakdown →
20151487
2
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Hit paper breakdown →
20181435
3
CRISPR-engineered T cells in patients with refractory cancer
Hit paper breakdown →
20201181
4
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Hit paper breakdown →
20141111
5
The Working Hours Of Hospital Staff Nurses And Patient Safety
Hit paper breakdown →
2004741
6
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
Hit paper breakdown →
2019648
7
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
Hit paper breakdown →
2012557
8
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Hit paper breakdown →
2011551
9 2015494
10
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Hit paper breakdown →
2022434
11
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
Hit paper breakdown →
2018407
12 2007334
13 2006330
14 2006319
15 2013291
16 2004282
17 2008279
18
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Hit paper breakdown →
2024267
19 2005245
20 2016237

About Wei‐Ting Hwang

Wei‐Ting Hwang is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Genetics, having authored 272 papers that have together received 21.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (33 papers), Breast Cancer Treatment Studies (26 papers), Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Childhood Cancer Survivors' Quality of Life (12 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Diversity and Career in Medicine (11 papers) and Bladder and Urothelial Cancer Treatments (11 papers). The work is most often cited by research in Oncology (7.9k citations), Virology (650 citations), Cancer Research (1.5k citations), Genetics (845 citations) and Research and Theory (327 citations). Wei‐Ting Hwang has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Lawrence J. Solin, Linda D. Scott, Ann E. Rogers, Carl H. June, Eleanor E R Harris, Bruce L. Levine, Curtiland Deville, David F. Dinges, Anne E. Kazak and Jan Joseph Melenhorst. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Blood, Cancer, Clinical Cancer Research and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact